References to Primary Literature
- HITCHCOCK CA, ANDREWS RJ, LEWIS BGH, TROKE PF: UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activ-ity in experimental infections with Cryptococcus. 35th Interscience Conference on Antimicrobial Agents and Che-motherapy San Francisco, California. (1995) Abstract 126.
- PALI ERSON BE, ROFFEY S, JEZEQUEL SG, JONES B: UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: disposition in man. 351h Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 126.
- DENNING D, DEL FAVERO A, GLUCKMAN E, NORFOLK D,RUHNKE M, YONREN 5, TROKE P, SARANTIS N: UK-109,496 a novel, wide- spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 126.
- DUPONT B, DENNING D, LODE H, YONREN S, TROKE P,SARANTIS N: UK-109,496 a novel, wide-spectrum tria-zole derivative for the treatment of fungal infections: clinical efficacy in chronic invasive aspergillosis. 35th Interscience Conference on Antimicrobial Agents and Che-motherapy. San Francisco, California. (1995) Abstract 127.
- SAKSENA AK, GIRIJAVALLABHAN VM, LOVEY RG, DESAIJA, PIKE RE, JAO E: SCH 51048, a novel broad-spectrum orally active antifungal agents: synthesis and prelimi-nary structure-activity profile. Bioorg. Med. Chem. Lett. (1995) 5:127–132.
- PARMEGIANI R, CACCIAPUOTI A, LOEBENBERG D, AN-TONACCI B, NORRIS C, YAROSII-TOMAINE T, MICHALSKI M, HARE RS, MILLER GH: In vitro activity of SCH 56592, a new antifungal agent. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 123.
- PERFECT JR, SCHELL WA: In vitro efficacy of the azole,SCH 56592, compared to amphotericin B, fluconazole, and itraconazole versus Cryptococcus neoformans. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 124.
- NOMEIR A, KUMARI P, HILBERT MJ, LOEBENBERG D, CACCIAPUOTI A, MENZEL F, MOSS JRE, HARE JRR, MILLER Gil, CAYEN MN, LIN CC: Comparative pharmacokinetics of a new triazole antifungal agent, SCH 56592, in mice, rats, rabbits, dogs and cynomolgus monkey. 35th Inter-science Conference on Antimicrobial Agents and Chemother-apy San Francisco, California. (1995) Abstract 124.
- CACCIAPUOTI A, PARMEGIANI R, LOEBENBERG D, AN-TONACCI B, MOSS EL, MENZEL JRF, NORRIS JAC, HARE RS, MILLER GH: Efficacy of SCH 56592 in pulmonary asper-gillosis and candidiasis in mice. 35rd Interscience Confer-ence on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 124.
- BARTROLI J, TURMO E, ALGUERO M, BONCOMPTE E, VERICAT ML, GARCIA-RAFANELL J, FORN J: Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring. J. Med. Chem. (1995) 38:3918–3932.
- BARTROLI J, TURMO E, BELLOC J, ALGUERO M, BON-COMPTE E, VERICAT L, ALMANSA C, CARCELLER E, GAR-CIARAFANELL J, FORN J: New N-acy1-2-morpholinones as potent orally active antifungal agents. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, Florida. (1994) Abstract 255.
- STEVENS DA, DEVINE MJ, MARTINEZ M, ARISTIZABAL B: /n vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746(U46) and UR-9751(1J51); comparison with fluconazole(F). 35th Inter-science Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 127.
- BORNAY-LLINARES FJ, TORRES-RODRIGUEZ JM: Anticryp-tococcal activity of a new azole derivative (UR-9746) in a murine modeL 35th Interscience Conference on Antimi-crobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 128.
- BORNAY-LLINNARES FJ, MAYOL-BELDA MS, ONRUBIA-PINTADO J, TORRES-RODRIGUEZ JM: Murine cryptococ-cosis. Tissular damage decreases after treatment with UR-9746. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 128.
- RESTREPO M, NAJVAR L, BARCHIESI F, GRAYBILL JR:Treatment of murine cryptococcal meningitis with UR-9751 and UR-9746. 35th Interscience Conference on Antimi-crobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 128.
- NAITO T, KAKU Y, TSURUOKA A, KAKINUMA H, TSUKADA I, YANAGISAWA M, NARA Y: ER-30346, a novel antifungal triazole: L Synthesis and structure-activity relation-ships of new thiazole- containing triazole antifungals. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 128.
- HATA K, UENO J, MIKI H, TOYOSAWA T, KATSU K, NAKAMURA T, HORIE T: ER-30346, a novel antifungal triazole: M. In vitro activity and its mode of action. 35th Interscience Conference on Antimicrobial Agents and Che-motherapy. San Francisco, California. (1995) Abstract 129.
- TOYOSAWA T, HATA K, UENO J, MIKI H, MORIYAMA M, KATSU K: ER-30346, a novel antifungal triazole: fl. in vivo activity against experimental infections. 35th Inter-science Conference on Antimicrobial Agents and Chemother-apy. San Francisco, California. (1995) Abstract 129.
- NAKAMLTRA T, SAKAI R, SONODA J, KATOH T, KANEKO T, HOKE T: ER-30346, a novel antifungal triazole: IV. Pharmacoltinetic and toxicological studies in mice, rats, and dogs. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, California. (1995) Abstract 129.
- YOTUJI A, SHIMIZU K, NISHIDA R, HORI R, ISHII N, YAMAMOTO 5, WATANABE Y, IMAIZUMI H, NARITA II: T-8581, a new orally and parenterally active triazole antiftmgal: in vitro and in vivo evaluation. 35th Inter-science Conference on Antimicrobial Agents and Chemother-apy. San Francisco, California. (1995) Abstract 127.
- HECTOR RE, YEE E: Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, men-ingeal cryptococcosis, and pulmonary aspergillosis. Antimicrob. Agents Chemother. (1990) 34:448–454.
- TANIO T, ICHSE K, NAKAJIMA T, OKUDA T: In vivo efficacy of SM- 8668 (Sch 39304), a new oral triazole antifungal agent Antimicrob. Agents Chemother. (1990) 34:980–984.
- PARMEGIANI RM, LOEBENBERG D,CACCIAPUOTI A, AN-TONACCI B, NORRIS C, MENZEL F, MOSS L, YAROSII-TOMAINE T, HARE RS, MILLER GH: SCH-39304, a new antifungal agents: oral and topical treatment of vaginal and superficial infections. J. Med. Vet. Myc. (1993) 31:239–248.
- HITCHCOCK CA, PYE GW, TROKE PF, JOHNSON EM, WARNOCK DW: Fluconazole resistance in Candkla glabrata. Anttmicrob. Agents Cbemother. (1993) 37:1962–1965.
- KITCHEN VS, SAVAGE M, HARRIS JRW: Candida albicans resistance in AIDS. J. Infect. (1991) 22:204–205.
- SMMI D, BOAG F, MIDGLEY J, GAZZARD 13: Fluconazole resistant Candida in AIDS. J, Infect. (1991) 23:345–346.
References to Patent Literature
- MOCHIDA PHARM. CO. LTD., EP-472392 (1993).
- ICI PLC., EP-174769 (1986).
- PFIZER, INC., EP-440372 (1991).
- PFIZER, INC., EP-122056 (1984).
- SCIIERING CORP., W09309114 (1993).
- SCHERING CORP., W09517407 (1995).
- J URIACH & CIA SA, EP-617031 (1994).
- SUMITOMO SEIYAKU KK, JP7188223 (1995).
- KAKEN PHARM. CO. LTD, JP6263757 (1994).
- EISAI CO., LTD. EP-667346 (1995).
- PFIZER, INC., W09307139 (1993).
- FUJISAWA PHARM. CO. LTD., W09506047 (1995).
- TA10EDA CHEM. IND. LTD., EP-659751 (1995).
- TOYAMA CHEM. CO. LTD., EP-546529 (1993).
- DAIKIN KOGYO ICK; TAISHO PHARM. CO. LTD., JP7070087 (1995).
- MOCHIDA PHARM. CO. LTD., EP-670315 (1995)
- SUMITOMO SEIYAKU KK,JP6247944 (1994)-
- TOKYO TANABE CO., JP6279419 (1994).
- ROUSSEL MORLSHITA CO. LTD., JP7188185 (1995).